Best Immunotherapy for breast cancer Doctors Worldwide — TOP 64

Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.

• Authored over 40 research publications focusing on tumor biology and immunology.
• Former Head of Internal Diseases at Istanbul Okan University Faculty of Medicine.
• Held leadership roles in medical oncology at GATA Haydarpasa Training Hospital.
• Member of the Turkish Medical Oncology Association and European Head and Neck Society.

Dr. Solak specializes in breast cancer treatment with a fellowship from Hacettepe University Cancer Institute – one of Turkey's leading oncology centers.

• Trained at The University of Texas MD Anderson Cancer Center
• Handles complex cases including ovarian and gastrointestinal cancers
• Residency completed at Istanbul Sisli Etfal Training and Research Hospital
• Focused on immunotherapy for various cancer types

Dr. Ari Raphael leads the TASMC oncology project of PSIFAS, Israel's National Genomic Medicine Initiative, focusing on immunotherapy for breast cancer.

• Senior Lecturer at Tel Aviv University
• Primary investigator for clinical trials on immunotherapy and genomic profiling
• Member of ESMO and IASLC
• Specializes in liquid biopsies and cell therapy

Dr. Agusti Barnadas Molins specializes in breast cancer immunotherapy as a medical oncologist at Centro Médico Teknon. His research has earned prestigious awards.

• Member of ESMO, ASCO, and SEOM – leading oncology societies
• Vice President of Spanish Breast Cancer Research Group (GEICAM)
• PhD in oncology from Universitat de Barcelona
• European Certification in Medical Oncology from London

Prof. Merimsky leads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center, with decades of expertise in sarcoma and breast cancer treatments.

• Over 41 years of experience specializing in tumor immunology and immunotherapy research
• Trained at prestigious Institut Gustave Roussy in Paris for sarcoma treatment
• Active member of ESMO sarcoma faculty and American Society of Clinical Oncology
• Published extensive research on breast cancer treatments including lobular carcinoma

Specialist with dedicated expertise in oncological gynecology and radiotherapy at Sourasky Medical Center.

• Specialized training in both surgical and radiation therapy approaches
• Handles complex breast cancer cases requiring combined treatment protocols
• Focuses on personalized therapy plans integrating latest immunotherapy options

Dr. Manuela Seifert leads the Breast Cancer Center in Solingen, specializing in breast-sparing surgeries and aesthetic reconstruction with over 26 years of experience of experience.

• Head of the Breast Cancer Center at Solingen Clinic
• Expert in breast-sparing techniques and plastic reconstruction
• Combines gynecology with plastic surgery for comprehensive care
• Offers psychological support throughout treatment and recovery

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Prof. Sezer Sağlam specializes in medical oncology with a focus on immunotherapy for breast cancer at Gayrettepe Florence Nightingale Hospital.

• Professor of medical oncology with extensive experience in gastrointestinal oncology
• Fellowship-trained at Istanbul University, one of Turkey's leading medical schools
• Member of prestigious organizations including ESMO and ASCO
• Over 27 years of experience of experience in treating complex cancer cases

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Dr. Osama Abdel Mohimen Mohamed leads the Hematology Unit at Shefaa Al Orman Oncology Hospital. He treats complex blood cancers, including leukemia, lymphoma, and myeloma. Dr. Mohamed is a member of the European Society for Medical Oncology. He also holds memberships in the American Society of Hematology and ASBMT.

• Specializes in chemotherapy, immunotherapy, and bone marrow transplantation.
• Manages aggressive acute leukemia and chronic blood disorders.
• Treats complications arising from various solid tumors.
• Works at an ESMO-accredited center that handles 6,000 patients annually.

Associate Professor at Istanbul Gaziosmanpaşa Taksim Education and Research Hospital with extensive expertise in breast cancer surgery and immunotherapy.

• Specialized in breast-conserving surgery and neoadjuvant chemotherapy
• Multiple international certificates in breast cancer treatment and reconstruction
• Published numerous research articles on breast cancer outcomes
• Over 29 years of experience of experience in general surgery

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Sinan Karaaslan specializes in breast cancer, colorectal, and urogenital cancers, with extensive experience in immunotherapy at Anadolu Medical Center.

• Over 29 years of experience focused on medical oncology
• Trained at Istanbul University's Cerrahpaşa Medical School
• Member of the Turkish Medical Oncology Society
• Works at a leading JCI-accredited hospital

Professor Yesim Yildirim specializes in cancer immunotherapy for breast cancer, with over 80 international publications and co-authored medical books.

• Member of the European Society of Medical Oncology (ESMO)
• Over a decade of experience at Anadolu Medical Center
• Trained at prestigious institutions including Rambam Medical Centre and Mount Vernon Cancer Center
• Professor at Haliç University, combining clinical practice with academic research

Assoc. Prof. Dr. Heves Sürmeli is a specialist in Internal Medicine and Medical Oncology. She received her medical degree (M.D.) from Eskişehir Osmangazi University in 2004. She completed her Internal Medicine residency at Kartal Dr. Lütfi Kırdar Training and Research Hospital, Istanbul (2005–2010). She then completed subspecialty training in Medical Oncology at the same hospital (2014–2017).

At the same center, she served as a Medical Oncology Specialist (2017–2023). She then worked as Administrative and Clinical Director (2023–2026). Her clinical interests include breast, lung, gynecologic, gastrointestinal, and urologic cancers.

She has published many articles in international peer‑reviewed journals. She has presented at national and international conferences. She is active in professional societies. She has received several awards.

Dr. Seref Komurcu is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, lung, colorectal, and solid cancers. Dr. Komurcu holds both ECFMG and ESMO certifications. He previously served as a professor at Gülhane Military Medical Academy.

• Published over 110 scientific papers on cancer management.
• Provides immunotherapy, targeted therapy, and chemotherapy treatments.
• Member of the American Society of Clinical Oncology.
• Works at a clinic affiliated with Johns Hopkins Medicine.

Dr. Eda Tanrikulu is a clinical oncologist at Anadolu Medical Center in Istanbul. She ranked 3rd nationally in Turkey's minor specialty medical exam. Dr. Tanrikulu specializes in chemotherapy and individualized cancer treatments. She works at a facility affiliated with the Johns Hopkins Hospital.

• Served as the head of the medical oncology unit at Haydarpaşa Numune Hospital.
• Participated in global training at Oxford University and ESMO in Manchester.
• Treats gastrointestinal, urological, lung, and breast cancers.
• Member of the American and European Societies of Medical Oncology.

Dr. Necdet Uskent is a medical oncologist and hematologist at Anadolu Medical Center in Istanbul. He was part of the pioneering team that performed Turkey's first bone marrow transplant. Dr. Uskent holds the European Medical Oncology Certificate and focuses on breast, lung, and gastrointestinal cancers. He works at a facility affiliated with Johns Hopkins Medicine.

• Founder of the Turkish Oncology Group (TOG).
• A founding member of the Turkish Society of Medical Oncology.
• Served as a visiting lecturer at Royal Free and University College Hospital in London.
• Treats complex hematological conditions including lymphomas and myeloma.